Thomas Jefferson UniversitySidney Kimmel Medical College

Main menu:

Patient Centered Risk Assessment & Communication

MISSION
To study patterns of patient-provider communication occurring in the clinical visit setting. To study research methodologies for research that is conducted in a patient-centered manner.

We seek to develop interventions and strategies in which patients understand and can respond to information in a way that promotes their health, both from a research and a clinical perspective.

We seek to help patients translate concepts of health risk into metrics (which are important and understandable to them) and help in identification of their risk factors using a shared decision making process with their primary care providers

GOALS

  • To add to the scientific literature in the areas of patient-centered communication and patient-centered outcomes research.
  • To acknowledge that any intervention for health risk reduction must take into account the patient’s perceptions and beliefs about health.
  • To increase patient participation in their health care by making it easier for them to express their priorities regarding behavioral risk reduction.

RECENT PROJECTS

  • Effect and underlying mechanisms of melatonin on blood pressure, insulin resistance, and endothelial function (Funder: National Heart, Lung, and Blood Institute)
  • Implementation of a Novel Hypertension Clinical Practice Guideline in a Large Primary Care Practice:  Process Evaluation, Uptake and Impact on Clinical Outcomes (Funder: AAFP Foundation)
  • Impact of adipokines and insulin resistance on progression of prehypertension (Funder: National Heart, Lung, and Blood Institute)
  • Patient Centered Cardiac Risk Assessment and Communication – Patient Perspectives– Mills and LaNoue
  • Patient Centered Cardiac Risk Assessment and Communication – Physician Perspectives
  • Target Organ Damage Outcomes for Prehypertension and Obesity in Black Adolescents–(Funder: National Heart, Lung, and Blood Institute)
  • TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control (Funder: Merck)

RECENT PRESENTATIONS

Mills G, LaNoue M, Cheng C, Payton C, Valko G. Implementation of a Hypertension Clinical Practice Guideline in a Large Academic Primary Care Practice. North American Primary Care Research Group Annual Meeting, New York, NY, November 2014.